Simplex Trading
EWTX icon

Simplex Trading’s Edgewise Therapeutics EWTX Stock Holding History

Simplex Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,832
Closed -$63.2K – 9558
2026
Q1 		$57.7K Sell
1,832
-7,237
-80% -$209K ﹤0.01% 5717
2025
Q4 		$225K Buy
9,069
+1,479
+19% +$29.7K ﹤0.01% 4107
2025
Q3 		$123K Buy
7,590
+3,407
+81% +$48.3K ﹤0.01% 5510
2025
Q2 		$54K Buy
+4,183
New +$60.3K ﹤0.01% 5851
2025
Q1 		– Sell
-50,130
Closed -$1.32M – 8790
2024
Q4 		$1.34M Sell
50,130
-23,900
-32% -$761K ﹤0.01% 2563
2024
Q3 		$1.98M Buy
74,030
+71,296
+2,608% +$1.42M ﹤0.01% 2286
2024
Q2 		$49K Sell
2,734
-291
-10% -$5.08K ﹤0.01% 6106
2024
Q1 		$55K Buy
+3,025
New +$48.1K ﹤0.01% 6177
2023
Q4 		– Sell
-371
Closed -$2.6K – 9060
2023
Q3 		$2K Sell
371
-2,158
-85% -$14.7K ﹤0.01% 8080
2023
Q2 		$19K Sell
2,529
-446
-15% -$3.76K ﹤0.01% 6822
2023
Q1 		$19K Buy
+2,975
New +$27.6K ﹤0.01% 6957

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's EWTX Position: Q2 2026 in Review

Simplex Trading sold out of Edgewise Therapeutics (EWTX) in Q2 2026, closing a stake of 1,832 shares — an estimated $63.2K sold.

Simplex Trading first reported a position in EWTX in Q1 2023 and held it in 11 quarters. The position peaked at $1.98M in Q3 2024. 227 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Simplex Trading reported no remaining Edgewise Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,832 Edgewise Therapeutics shares in Q2 2026, an estimated $63.2K.
  • Simplex Trading first reported a position in Edgewise Therapeutics in Q1 2023 and held it in 11 quarters.
  • Simplex Trading's Edgewise Therapeutics position peaked at $1.98M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.